|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Net sales | |||||
| Cost of sales | |||||
| Gross profit | |||||
| Selling, general and administrative expense | |||||
| Research, development and engineering expense | |||||
| Acquisition and restructuring related expense | |||||
| Amortization of intangible assets | |||||
| Operating income | |||||
| Interest expense, net | |||||
| Loss on debt extinguishment | |||||
| Other expense (income), net | |||||
| Total other expense | |||||
| Total | |||||
| Provision for income taxes | |||||
| Net income | |||||
| Foreign currency translation adjustments, net of tax expense (benefit) of $763, $(1,430), and $1,498, respectively | |||||
| Change in fair value of derivatives, net of tax expense (benefit) of $1,620, $(994), and $(3,309), respectively | |||||
| Comprehensive income | |||||
| Earnings per share | |||||
| Basic (in usd per share) | |||||
| Diluted (in usd per share) | |||||
| Weighted average common shares outstanding | |||||
| Basic (in shares) | |||||
| Diluted (in shares) |
Loading...